Search results

I'm always keen to see good epidemiological studies of Long Covid/PCS. I haven't read very far, but I am already doubting that this is one. About the same percentage of people had one or more persistent symptoms more than 90 days after SARS-CoV-2 infection as people more than 90 days after a...

Welcome to the forum @TinyBird10. I'm sorry that you are experiencing that; it sounds very frustrating. Most of us are not doctors and none of us can offer you an informed diagnosis - we have a rule that doesn't allow us to provide medical advice, recognising the dangers of us trying to...

It does look good @bobbler I couldn't help reading this in the context of Cochrane I don't feel listened to When you ask for people's input into developing services, it's important to be open and honest, and to build trust. People using our services gave us a clear message when we were...

Yeah, retrospective self-report, with self-selected recruitment. Number of people who had not been infected is relatively small, and so they might be different to the people who were infected - some sociodemographic difference that changes the incidence of menstrual changes. Same problem -...

@Peter Trewhitt writes about the silence and secrecy of the past two years. Actually it mostly continues. A large chunk of the international ME/CFS advocacy machinery is presumably tied up in confidentiality agreements. #MEAction's silence seems to cover the US head organisation and its US...

It's a nice summary of events @dave30th, thank you. Also some great comments on the blog @Peter Trewhitt, @Snow Leopard.

Yes, I think this is a key point to use in advocacy. You can't have an organisation that publishes clinical guidance but does not have the resources to follow its own stated complaint processes, to appropriately deal with feedback that can help identify and remove information that is incorrect...

EMA is European Medicines Authority The agenda looks really interesting and useful; looks like a practical focus on getting good trials done. Pfizer is there talking about the challenges of clinical trials. There's a couple of patient representatives. Hopefully the event will be recorded; the...

Thanks SNT. Sorry about that, I've changed the title thread.

The saga continues - more correspondence with Cochrane: S4ME: 2023 Open Letter to Cochrane - request for action on the ME/CFS Exercise Therapy Review

I think there's a lot to like about this study. It's worth clicking through to the fuller explanation, which is still just a summary. One thing is this - the Fred and Joan Davies Bequest. I haven't heard of it, but it is really lovely that people cared enough to donate money in a bequest...

Thanks SNT, it looks useful. There's a reader's survey asking for ideas for stories and resources. I mentioned the Cochrane issue (and the petition), as well as the trend for ME/CFS to be disappeared, replaced with diagnoses of Long Covid and psychosomatic Functional Disorders. And this forum.

There is a paywall. I'm interested to see some quotes about those points you mention.

This, and even then the low quality rating is only for a small number of outcomes, almost all of which are short term outcomes. The evidence for the rest of the outcomes is rated 'very low quality'. You would think that any effective treatment for chronic fatigue syndrome would have some clear...

I find this a bit horrifying - here is the reality of the BPS capture of Long Covid. People with persistent symptoms, with physical incapacity, are going to this clinic for help and, according to the abstract, the response is to tell 91% to exercise. 76% appear to be diagnosed with functional...

A new thread has been created for the discussion of the content of Hilda Bastian's talkpage facility here: Cochrane - Exercise therapy review - Hilda Bastian's Talkpage

Here is the reply I posted on Hilda's talk page. A couple of my posts are not appearing on that platform, so I'm going to record them in the forum. Others might want to do the same. Hilda, You seem to be suggesting that the fact that NICE didn't rate all the evidence relating to GET as 'very...

From NICE https://www.nice.org.uk/guidance/ng206/evidence/g-nonpharmacological-management-of-mecfs-pdf-9265183028 page 384 This has the bit about the lack of clinically important differences for many of the outcomes. It also has the interesting news that when the NICE team had a look at the...

So, I make that 1. All five of the objective outcomes rated as very low quality evidence 2. Of the 20 subjective outcomes, 14 were rated as very low quality evidence. 3. Of the 25 outcomes, 19 were rated as very low quality evidence. (Possibly I didn't get them all, I didn't double check, but...

The NICE Guideline committee of course was labouring under the weight of a number of people who were desperate to show that BPS methods worked. And was the analysis of the trials perfect? No, it wasn't. But here are the results of the quality assessments GET versus standard care, as Hilda...